Bacsan, Liam F.
HRN: 21-87-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2022
CEFTAZIDIME 1GM (VIAL)
09/09/2022
09/16/2022
IV
105mg
Q8
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes